A health worker talks to people as they wait to register next to the Transvaco coronavirus disease (COVID-19) vaccine train, at the Springs train station on the East Rand, South Africa, August 30, 2021. (Photo: REUTERS) |
The UK Health Security Agency said that the variant - called B.1.1.529 - has a spike protein that was dramatically different to the one in the original coronavirus that COVID-19 vaccines are based on.
Officials have advised the government on the need to act swiftly and pre-emptively in case the concerns over the impact of the variant are borne out, even though it could take weeks to generate all the information needed about its characteristics.

